Terms: = Endocrine gland cancer AND SDC4, ENSG00000124145, 6385, P31431, SYND4, MGC22217 AND Prognosis
4 results:
1. Spatial transcriptomics reveals prognosis-associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment.
Yan K; Liu QZ; Huang RR; Jiang YH; Bian ZH; Li SJ; Li L; Shen F; Tsuneyama K; Zhang QL; Lian ZX; Guan H; Xu B
Clin Transl Med; 2024 Mar; 14(3):e1594. PubMed ID: 38426403
[TBL] [Abstract] [Full Text] [Related]
2. Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer.
Carvalho RF; do Canto LM; Abildgaard C; Aagaard MM; Tronhjem MS; Waldstrøm M; Jensen LH; Steffensen KD; Rogatto SR
Cell Commun Signal; 2022 Nov; 20(1):176. PubMed ID: 36352420
[TBL] [Abstract] [Full Text] [Related]
3. High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma.
Zhu Y; Zheng D; Lei L; Cai K; Xie H; Zheng J; Yu C
BMC Cancer; 2022 Oct; 22(1):1042. PubMed ID: 36199068
[TBL] [Abstract] [Full Text] [Related]
4. Identifying key genes of classic papillary thyroid cancer in women aged more than 55 years old using bioinformatics analysis.
Li CC; Ullah MHE; Lin X; Shan SK; Guo B; Zheng MH; Wang Y; Li F; Yuan LQ
Front Endocrinol (Lausanne); 2022; 13():948285. PubMed ID: 36120433
[TBL] [Abstract] [Full Text] [Related]
